table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Biopsy Overall Market Size
2.1 Global Cancer Biopsy Market Size: 2022 VS 2029
2.2 Global Cancer Biopsy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Biopsy Players in Global Market
3.2 Top Global Cancer Biopsy Companies Ranked by Revenue
3.3 Global Cancer Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biopsy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Biopsy Market Size Markets, 2022 & 2029
4.1.2 Tissue Biopsies
4.1.3 Liquid Biopsies
4.1.4 Others
4.2 By Type - Global Cancer Biopsy Revenue & Forecasts
4.2.1 By Type - Global Cancer Biopsy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Biopsy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Biopsy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Biopsy Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Colorectal Cancer
5.1.4 Cervical Cancers
5.1.5 Lung Cancers
5.1.6 Prostate Cancers
5.1.7 Skin Cancers
5.1.8 Blood Cancers
5.1.9 Kidney Cancers
5.1.10 Others
5.2 By Application - Global Cancer Biopsy Revenue & Forecasts
5.2.1 By Application - Global Cancer Biopsy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Biopsy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Biopsy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Biopsy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Biopsy Revenue & Forecasts
6.2.1 By Region - Global Cancer Biopsy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Biopsy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Biopsy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Biopsy Revenue, 2018-2029
6.3.2 US Cancer Biopsy Market Size, 2018-2029
6.3.3 Canada Cancer Biopsy Market Size, 2018-2029
6.3.4 Mexico Cancer Biopsy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Biopsy Revenue, 2018-2029
6.4.2 Germany Cancer Biopsy Market Size, 2018-2029
6.4.3 France Cancer Biopsy Market Size, 2018-2029
6.4.4 U.K. Cancer Biopsy Market Size, 2018-2029
6.4.5 Italy Cancer Biopsy Market Size, 2018-2029
6.4.6 Russia Cancer Biopsy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Biopsy Market Size, 2018-2029
6.4.8 Benelux Cancer Biopsy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Biopsy Revenue, 2018-2029
6.5.2 China Cancer Biopsy Market Size, 2018-2029
6.5.3 Japan Cancer Biopsy Market Size, 2018-2029
6.5.4 South Korea Cancer Biopsy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Biopsy Market Size, 2018-2029
6.5.6 India Cancer Biopsy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Biopsy Revenue, 2018-2029
6.6.2 Brazil Cancer Biopsy Market Size, 2018-2029
6.6.3 Argentina Cancer Biopsy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Biopsy Revenue, 2018-2029
6.7.2 Turkey Cancer Biopsy Market Size, 2018-2029
6.7.3 Israel Cancer Biopsy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Biopsy Market Size, 2018-2029
6.7.5 UAE Cancer Biopsy Market Size, 2018-2029
7 Cancer Biopsy Companies Profiles
7.1 Qiagen N.V.
7.1.1 Qiagen N.V. Company Summary
7.1.2 Qiagen N.V. Business Overview
7.1.3 Qiagen N.V. Cancer Biopsy Major Product Offerings
7.1.4 Qiagen N.V. Cancer Biopsy Revenue in Global Market (2018-2023)
7.1.5 Qiagen N.V. Key News & Latest Developments
7.2 Illumina, Inc.
7.2.1 Illumina, Inc. Company Summary
7.2.2 Illumina, Inc. Business Overview
7.2.3 Illumina, Inc. Cancer Biopsy Major Product Offerings
7.2.4 Illumina, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.2.5 Illumina, Inc. Key News & Latest Developments
7.3 ANGLE Plc
7.3.1 ANGLE Plc Company Summary
7.3.2 ANGLE Plc Business Overview
7.3.3 ANGLE Plc Cancer Biopsy Major Product Offerings
7.3.4 ANGLE Plc Cancer Biopsy Revenue in Global Market (2018-2023)
7.3.5 ANGLE Plc Key News & Latest Developments
7.4 Myriad Genetics
7.4.1 Myriad Genetics Company Summary
7.4.2 Myriad Genetics Business Overview
7.4.3 Myriad Genetics Cancer Biopsy Major Product Offerings
7.4.4 Myriad Genetics Cancer Biopsy Revenue in Global Market (2018-2023)
7.4.5 Myriad Genetics Key News & Latest Developments
7.5 Hologic, Inc.
7.5.1 Hologic, Inc. Company Summary
7.5.2 Hologic, Inc. Business Overview
7.5.3 Hologic, Inc. Cancer Biopsy Major Product Offerings
7.5.4 Hologic, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.5.5 Hologic, Inc. Key News & Latest Developments
7.6 Biocept, Inc.
7.6.1 Biocept, Inc. Company Summary
7.6.2 Biocept, Inc. Business Overview
7.6.3 Biocept, Inc. Cancer Biopsy Major Product Offerings
7.6.4 Biocept, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.6.5 Biocept, Inc. Key News & Latest Developments
7.7 Thermo Fisher Scientific, Inc.
7.7.1 Thermo Fisher Scientific, Inc. Company Summary
7.7.2 Thermo Fisher Scientific, Inc. Business Overview
7.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Major Product Offerings
7.7.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.7.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.8 Danaher
7.8.1 Danaher Company Summary
7.8.2 Danaher Business Overview
7.8.3 Danaher Cancer Biopsy Major Product Offerings
7.8.4 Danaher Cancer Biopsy Revenue in Global Market (2018-2023)
7.8.5 Danaher Key News & Latest Developments
7.9 Lucence Diagnostics Pte. Ltd.
7.9.1 Lucence Diagnostics Pte. Ltd. Company Summary
7.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
7.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Major Product Offerings
7.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue in Global Market (2018-2023)
7.9.5 Lucence Diagnostics Pte. Ltd. Key News & Latest Developments
7.10 GRAIL, Inc.
7.10.1 GRAIL, Inc. Company Summary
7.10.2 GRAIL, Inc. Business Overview
7.10.3 GRAIL, Inc. Cancer Biopsy Major Product Offerings
7.10.4 GRAIL, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.10.5 GRAIL, Inc. Key News & Latest Developments
7.11 Guardant Health
7.11.1 Guardant Health Company Summary
7.11.2 Guardant Health Business Overview
7.11.3 Guardant Health Cancer Biopsy Major Product Offerings
7.11.4 Guardant Health Cancer Biopsy Revenue in Global Market (2018-2023)
7.11.5 Guardant Health Key News & Latest Developments
7.12 Exact Sciences Corporation
7.12.1 Exact Sciences Corporation Company Summary
7.12.2 Exact Sciences Corporation Business Overview
7.12.3 Exact Sciences Corporation Cancer Biopsy Major Product Offerings
7.12.4 Exact Sciences Corporation Cancer Biopsy Revenue in Global Market (2018-2023)
7.12.5 Exact Sciences Corporation Key News & Latest Developments
7.13 Freenome Holdings, Inc.
7.13.1 Freenome Holdings, Inc. Company Summary
7.13.2 Freenome Holdings, Inc. Business Overview
7.13.3 Freenome Holdings, Inc. Cancer Biopsy Major Product Offerings
7.13.4 Freenome Holdings, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.13.5 Freenome Holdings, Inc. Key News & Latest Developments
7.14 Oncimmune
7.14.1 Oncimmune Company Summary
7.14.2 Oncimmune Business Overview
7.14.3 Oncimmune Cancer Biopsy Major Product Offerings
7.14.4 Oncimmune Cancer Biopsy Revenue in Global Market (2018-2023)
7.14.5 Oncimmune Key News & Latest Developments
7.15 Chronix Biomedical, Inc.
7.15.1 Chronix Biomedical, Inc. Company Summary
7.15.2 Chronix Biomedical, Inc. Business Overview
7.15.3 Chronix Biomedical, Inc. Cancer Biopsy Major Product Offerings
7.15.4 Chronix Biomedical, Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.15.5 Chronix Biomedical, Inc. Key News & Latest Developments
7.16 Personal Genome Diagnostics Inc.
7.16.1 Personal Genome Diagnostics Inc. Company Summary
7.16.2 Personal Genome Diagnostics Inc. Business Overview
7.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Major Product Offerings
7.16.4 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue in Global Market (2018-2023)
7.16.5 Personal Genome Diagnostics Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
